Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.03
THC's Cash to Debt is ranked lower than
90% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.31 vs. THC: 0.03 )
Ranked among companies with meaningful Cash to Debt only.
THC' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.04 Max: 0.35
Current: 0.03
0
0.35
Equity to Asset 0.04
THC's Equity to Asset is ranked lower than
90% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. THC: 0.04 )
Ranked among companies with meaningful Equity to Asset only.
THC' s Equity to Asset Range Over the Past 10 Years
Min: 0  Med: 0.20 Max: 0.43
Current: 0.04
0
0.43
Interest Coverage 1.25
THC's Interest Coverage is ranked lower than
90% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 9.36 vs. THC: 1.25 )
Ranked among companies with meaningful Interest Coverage only.
THC' s Interest Coverage Range Over the Past 10 Years
Min: 0.62  Med: 1.32 Max: 1.82
Current: 1.25
0.62
1.82
F-Score: 8
Z-Score: 1.03
WACC vs ROIC
5.12%
5.34%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 5.96
THC's Operating margin (%) is ranked lower than
59% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. THC: 5.96 )
Ranked among companies with meaningful Operating margin (%) only.
THC' s Operating margin (%) Range Over the Past 10 Years
Min: -8.66  Med: 5.77 Max: 8.21
Current: 5.96
-8.66
8.21
Net-margin (%) 0.10
THC's Net-margin (%) is ranked lower than
74% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. THC: 0.10 )
Ranked among companies with meaningful Net-margin (%) only.
THC' s Net-margin (%) Range Over the Past 10 Years
Min: -9.5  Med: 0.18 Max: 13.5
Current: 0.1
-9.5
13.5
ROE (%) 2.35
THC's ROE (%) is ranked lower than
75% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 9.24 vs. THC: 2.35 )
Ranked among companies with meaningful ROE (%) only.
THC' s ROE (%) Range Over the Past 10 Years
Min: -124.98  Med: 2.68 Max: 92.79
Current: 2.35
-124.98
92.79
ROA (%) 0.09
THC's ROA (%) is ranked lower than
74% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 3.51 vs. THC: 0.09 )
Ranked among companies with meaningful ROA (%) only.
THC' s ROA (%) Range Over the Past 10 Years
Min: -8.75  Med: 0.19 Max: 13.89
Current: 0.09
-8.75
13.89
ROC (Joel Greenblatt) (%) 11.95
THC's ROC (Joel Greenblatt) (%) is ranked lower than
60% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 20.18 vs. THC: 11.95 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
THC' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: -14.52  Med: 10.44 Max: 15.25
Current: 11.95
-14.52
15.25
Revenue Growth (3Y)(%) 32.40
THC's Revenue Growth (3Y)(%) is ranked higher than
96% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. THC: 32.40 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
THC' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -13.7  Med: -0.25 Max: 32.4
Current: 32.4
-13.7
32.4
EBITDA Growth (3Y)(%) 31.20
THC's EBITDA Growth (3Y)(%) is ranked higher than
88% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. THC: 31.20 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
THC' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -47.2  Med: 7.75 Max: 31.5
Current: 31.2
-47.2
31.5
EPS Growth (3Y)(%) -15.30
THC's EPS Growth (3Y)(%) is ranked lower than
83% of the 118 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. THC: -15.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
THC' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -69.8  Med: -5.30 Max: 57
Current: -15.3
-69.8
57
» THC's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2015

THC Guru Trades in Q2 2015

Jim Simons 37,775 sh (New)
Joel Greenblatt 20,284 sh (New)
Steven Cohen 4,000 sh (New)
Louis Moore Bacon 170,176 sh (+520.54%)
Paul Tudor Jones 19,326 sh (+168.98%)
Larry Robbins 14,792,313 sh (+7.09%)
Mario Gabelli 15,050 sh (unchged)
Richard Perry Sold Out
Paul Singer Sold Out
Vanguard Health Care Fund 1,399,100 sh (-31.86%)
» More
Q3 2015

THC Guru Trades in Q3 2015

Ray Dalio 10,647 sh (New)
Steven Cohen 462,600 sh (+11465.00%)
Jim Simons 197,675 sh (+423.30%)
Larry Robbins 16,490,230 sh (+11.48%)
Larry Robbins 16,490,230 sh (+11.48%)
Louis Moore Bacon Sold Out
Vanguard Health Care Fund Sold Out
Joel Greenblatt Sold Out
Mario Gabelli 15,040 sh (-0.07%)
Paul Tudor Jones 5,600 sh (-71.02%)
» More
Q4 2015

THC Guru Trades in Q4 2015

Mario Gabelli 15,040 sh (unchged)
Larry Robbins 17,890,230 sh (unchged)
» More
2016

THC Guru Trades in 2016

Larry Robbins 17,900,928 sh (+0.06%)
Larry Robbins 17,890,230 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with THC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Tenet Healthcare Corp

Guru, Philanthropist Larry Robbins Adds to 3 Healthcare-Related Holdings Robbins increased his stake in insurance company Humana
Guru Larry Robbins (Trades, Portfolio), the founder and CEO of Glenview Capital Management, also serves on the Robin Hood Foundation Board of Directors, as well as the board for Teach for America. Read more...
Larry Robbins Raises Stake in Tenet Healthcare Guru's position goes up 11% with purchase of nearly 1.7 million shares
Larry Robbins (Trades, Portfolio), founder, portfolio manager and CEO of hedge fund Glenview Capital Management, raised his stake in Tenet Healthcare Corp. (NYSE:THC) Wednesday by more than 11% with the purchase of 1,697,917 shares for an average price of $36.30 per share. The purchase had a 0.24% impact on Robbins’ portfolio. Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 194.80
THC's P/E(ttm) is ranked lower than
98% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 27.90 vs. THC: 194.80 )
Ranked among companies with meaningful P/E(ttm) only.
THC' s P/E(ttm) Range Over the Past 10 Years
Min: 1.87  Med: 20.91 Max: 978.3
Current: 194.8
1.87
978.3
Forward P/E 8.75
THC's Forward P/E is ranked higher than
88% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 16.75 vs. THC: 8.75 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 185.10
THC's PE(NRI) is ranked lower than
97% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 24.85 vs. THC: 185.10 )
Ranked among companies with meaningful PE(NRI) only.
THC' s PE(NRI) Range Over the Past 10 Years
Min: 1.51  Med: 26.05 Max: 1296
Current: 185.1
1.51
1296
P/B 3.22
THC's P/B is ranked lower than
67% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 2.53 vs. THC: 3.22 )
Ranked among companies with meaningful P/B only.
THC' s P/B Range Over the Past 10 Years
Min: 1.37  Med: 5.10 Max: 101.5
Current: 3.22
1.37
101.5
P/S 0.15
THC's P/S is ranked higher than
97% of the 301 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. THC: 0.15 )
Ranked among companies with meaningful P/S only.
THC' s P/S Range Over the Past 10 Years
Min: 0.05  Med: 0.33 Max: 0.72
Current: 0.15
0.05
0.72
PFCF 8.87
THC's PFCF is ranked higher than
86% of the 202 Companies
in the Global Medical Care industry.

( Industry Median: 20.37 vs. THC: 8.87 )
Ranked among companies with meaningful PFCF only.
THC' s PFCF Range Over the Past 10 Years
Min: 7.9  Med: 98.36 Max: 676
Current: 8.87
7.9
676
POCF 2.49
THC's POCF is ranked higher than
96% of the 275 Companies
in the Global Medical Care industry.

( Industry Median: 14.09 vs. THC: 2.49 )
Ranked among companies with meaningful POCF only.
THC' s POCF Range Over the Past 10 Years
Min: 1.31  Med: 7.00 Max: 15.72
Current: 2.49
1.31
15.72
EV-to-EBIT 15.86
THC's EV-to-EBIT is ranked higher than
56% of the 290 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. THC: 15.86 )
Ranked among companies with meaningful EV-to-EBIT only.
THC' s EV-to-EBIT Range Over the Past 10 Years
Min: -274.4  Med: 13.40 Max: 1356.9
Current: 15.86
-274.4
1356.9
EV-to-EBITDA 8.97
THC's EV-to-EBITDA is ranked higher than
75% of the 303 Companies
in the Global Medical Care industry.

( Industry Median: 12.05 vs. THC: 8.97 )
Ranked among companies with meaningful EV-to-EBITDA only.
THC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -34  Med: 7.90 Max: 22.7
Current: 8.97
-34
22.7
PEG 13.22
THC's PEG is ranked lower than
96% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 2.75 vs. THC: 13.22 )
Ranked among companies with meaningful PEG only.
THC' s PEG Range Over the Past 10 Years
Min: 2.44  Med: 4.51 Max: 23.7
Current: 13.22
2.44
23.7
Current Ratio 1.54
THC's Current Ratio is ranked higher than
65% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. THC: 1.54 )
Ranked among companies with meaningful Current Ratio only.
THC' s Current Ratio Range Over the Past 10 Years
Min: 1.19  Med: 1.53 Max: 2.38
Current: 1.54
1.19
2.38
Quick Ratio 1.47
THC's Quick Ratio is ranked higher than
64% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. THC: 1.47 )
Ranked among companies with meaningful Quick Ratio only.
THC' s Quick Ratio Range Over the Past 10 Years
Min: 1.11  Med: 1.42 Max: 2.29
Current: 1.47
1.11
2.29
Days Inventory 8.55
THC's Days Inventory is ranked higher than
72% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 16.67 vs. THC: 8.55 )
Ranked among companies with meaningful Days Inventory only.
THC' s Days Inventory Range Over the Past 10 Years
Min: 9.18  Med: 10.55 Max: 13.2
Current: 8.55
9.18
13.2
Days Sales Outstanding 50.95
THC's Days Sales Outstanding is ranked lower than
58% of the 187 Companies
in the Global Medical Care industry.

( Industry Median: 45.70 vs. THC: 50.95 )
Ranked among companies with meaningful Days Sales Outstanding only.
THC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.89  Med: 55.37 Max: 70.14
Current: 50.95
46.89
70.14
Days Payable 38.21
THC's Days Payable is ranked lower than
53% of the 144 Companies
in the Global Medical Care industry.

( Industry Median: 42.47 vs. THC: 38.21 )
Ranked among companies with meaningful Days Payable only.
THC' s Days Payable Range Over the Past 10 Years
Min: 40.4  Med: 49.79 Max: 58.76
Current: 38.21
40.4
58.76

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 4.67
THC's Price/Projected FCF is ranked lower than
90% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. THC: 4.67 )
Ranked among companies with meaningful Price/Projected FCF only.
THC' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.67  Med: 1.15 Max: 130.86
Current: 4.67
0.67
130.86
Price/Median PS Value 0.44
THC's Price/Median PS Value is ranked higher than
94% of the 300 Companies
in the Global Medical Care industry.

( Industry Median: 1.05 vs. THC: 0.44 )
Ranked among companies with meaningful Price/Median PS Value only.
THC' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.19  Med: 1.46 Max: 5.44
Current: 0.44
0.19
5.44
Price/Peter Lynch Fair Value 8.12
THC's Price/Peter Lynch Fair Value is ranked higher than
74% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 2.47 vs. THC: 8.12 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
THC' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.44  Med: 2.76 Max: 23.21
Current: 8.12
0.44
23.21
Earnings Yield (Greenblatt) (%) 6.30
THC's Earnings Yield (Greenblatt) (%) is ranked higher than
62% of the 211 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. THC: 6.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
THC' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.1  Med: 6.30 Max: 15.7
Current: 6.3
0.1
15.7
Forward Rate of Return (Yacktman) (%) 22.92
THC's Forward Rate of Return (Yacktman) (%) is ranked higher than
84% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 10.04 vs. THC: 22.92 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
THC' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -103.1  Med: 0.50 Max: 22.9
Current: 22.92
-103.1
22.9

More Statistics

Revenue(Mil) $18089
EPS $ 0.13
Beta0.84
Short Percentage of Float15.03%
52-Week Range $21.91 - 60.93
Shares Outstanding(Mil)99.67

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 18,347 19,052 20,223
EPS($) 1.93 2.14 2.96
EPS without NRI($) 1.93 2.14 2.96

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:THC1.Germany,
Tenet Healthcare Corp, a Nevada corporation was incorporated in 1975. It is an investor-owned company whose subsidiaries and affiliates operate regionally focused, integrated health care delivery networks with a significant presence in several large urban and suburban markets. At the core of its networks are acute care and specialty hospitals that, together with its strategically aligned outpatient facilities and related businesses, allow them to provide a comprehensive range of health care services in the communities they serve. The Company primarily operated 77 hospitals, 183 outpatient centers, six health plans, six accountable care networks and Conifer Health Solutions, LLC ("Conifer"), which provides business process solutions to more than 700 hospital and other clients nationwide. It provides comprehensive operational management for revenue cycle functions, including patient access, health information management, revenue integrity and patient financial services. They also offer communications and engagement solutions to optimize the relationship between providers and patients. In addition, its management services offerings have expanded to support value-based performance through clinical integration, financial risk management and population health management. For financial reporting purposes, its business lines are classified into two separate reportable business segments - hospital operations and other, and Conifer. Its subsidiaries operated 77 hospitals, including four academic medical centers, two children's hospitals, three specialty hospitals and a critical access hospital, with a total of 20,293 licensed beds, serving primarily urban and suburban communities in 14 states. Of those hospitals, 72 were owned by its subsidiaries, and five were owned by third parties and leased by its subsidiaries. They are also in the process of constructing the new Resolute Health Hospital and Wellness Campus in New Braunfels, Texas, which is expected to be completed in or around May 2014. In addition, its subsidiaries operated a long-term acute care hospital and owned or leased and operated a number of medical office buildings, all of which were located on, or nearby, its hospital campuses. Furthermore, its subsidiaries operated 183 free-standing and provider-based outpatient centers in 16 states including diagnostic imaging centers, ambulatory surgery centers, urgent care centers and satellite emergency departments, among others. They also owned over 500 physician practices. Many of its hospitals also offer a wide range of clinical research studies, giving patients access to innovative care. The Company also own or control six accountable care networks - in Florida, California, Illinois, Michigan and Texas - and participate in two additional accountable care networks through collaborations with other health care providers in its markets in Arizona and Massachusetts. These networks operate using a range of payment and delivery models th

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK